You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 4, January 27, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Controversies
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (73)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Drug Therapy, Other
 •Alert me on articles by topic

Direct-to-Consumer Prescription Drug Advertising Builds Bridges Between Patients and Physicians

Alan F. Holmer, JD

JAMA. 1999;281:380-382.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Direct-to-consumer (DTC) advertising is an excellent way to meet the growing demand for medical information, empowering consumers by educating them about health conditions and possible treatments. By so doing, it can play an important role in improving public health.

"In health care, there is a general trend toward having consumers more responsible for their own health," according to Linda Golodner, president of the National Consumers League.1

The sources of user-accessible information about health care have increased exponentially just in the past few years. More than 50 consumer magazines about health care appear on the newsstands every month. Many television stations have a physician dispensing medical news. Nearly one quarter of the Internet is devoted to health care information.2 The Physicians' Desk Reference, once largely confined to physicians' offices, is now available in a consumer edition at pharmacy counters.

Along with these sources, DTC advertising is a . . . [Full Text of this Article]

Author Affiliation: Mr Holmer is president, Pharmaceutical Research and Manufacturers of America, Washington, DC.


RELATED ARTICLE

Direct-to-Consumer Marketing of Prescription Drugs: Creating Consumer Demand
Matthew F. Hollon
JAMA. 1999;281(4):382-384.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.